What Adagio Medical Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 0 |
| Total trades | 0 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 222,315 |
| Disposed | 0 | 0 |
| Net activity | +0 | +222,315 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kaster Deborah | Chief Financial Officer | Dec 16 | Open-market buy · P | +15,000 | $1.20 | +$18K | 15,000 |
| Usen Todd | Chief Executive Officer | Dec 12 | Open-market buy · P | +207,315 | $1.09 | +$226K | 207,315 |
| Perceptive Advisors Llc | Director | Jan 22 | Grant / award · A | +64,167 | — | — | 9,675,684 |
| Mirsaeedi-Farahani Keyvan | Director | Sep 27 | Other Transaction · J | +12,770 | — | — | 12,770 |
| Arya Sciences Holdings Iv | 10% owner | Sep 27 | Other Transaction · J | −3,501,600 | — | — | 0 |
| Cox James L | Director | Jul 31 | Other Transaction · J | +36,698 | — | — | 36,698 |
| Bergheim Olav | CEO | Jul 31 | Other Transaction · J | +22,081 | — | — | 22,081 |
| Bergheim Olav | CEO | Jul 31 | Other Transaction · J | +212,053 | — | — | 212,053 |
| Bergheim Hakon | Chief Operating Officer | Jul 31 | Other Transaction · J | +7,539 | — | — | 7,539 |
Loading...
